超声血管指数定量、弹性模量与乳腺癌生物学特征关系及其变化的临床意义

Relationships of ultrasound vascular index quantification and elastic modulus with biological characteristics of breast cancer and its clinical significance

  • 摘要:
    目的 探讨超声血管指数定量、弹性模量值与乳腺癌生物学特征关系及其变化的临床意义。
    方法 选取接受新辅助化疗(NAC)治疗的103例乳腺癌患者为研究对象, 分析NAC前超微血管成像(SMI)的血管指数(VI)、剪切波弹性成像(SWE)最大弹性模量值(Emax)与乳腺癌生物学特征关系。根据NAC的病理反应结果分为显著反应组、非显著反应组,比较2组NAC不同周期末VI变化率、Emax变化率。采用受试者工作特征(ROC)曲线分析不同周期末VI变化率、Emax变化率预测乳腺癌NAC病理反应。
    结果 NAC前VI、Emax与乳腺癌组织分化程度、病理分期及癌组织HER-2表达有关(P < 0.05)。显著反应组NAC第1、2、4周期末的VI变化率和Emax变化率均高于非显著反应组,差异有统计学意义(P < 0.01)。第2周期末的VI变化率联合Emax变化率预测乳腺癌NAC病理反应的AUC为0.918、灵敏度为0.874、特异度为0.905, 高于第1周期末VI变化率联合Emax变化率的AUC(0.832)、灵敏度(0.788)、特异度(0.827), 也高于第4周期末VI变化率联合Emax变化率的AUC(0.853)、灵敏度(0.827)、特异度(0.849)。
    结论 VI、Emax与乳腺癌分化程度、病理分期及癌组织HER-2表达存在关联,化疗第2周期末VI变化率联合Emax变化率预测乳腺癌NAC病理反应效能最优。

     

    Abstract:
    Objective To explore the relationships of ultrasound vascular index quantification and elastic modulus with biological characteristics of breast cancer and its clinical significance.
    Methods A total of 103 patients with breast cancer who received neoadjuvant chemotherapy (NAC) were selected as study subjects. The relationships of the quantification of vascular index (VI) and maximum elastic modulus (Emax) of shear wave elastography (SWE) with the biological characteristics of breast cancer before NAC were analyzed. According to the pathological response of NAC, the patients were divided into significant response group and non-significant response group. The change rates of VI and Emax at the end of different cycles of NAC were compared between the two groups. Receiver operating characteristic (ROC) curve was used to analyze the change rates of VI and Emax at the end of different cycles to predict the pathological response of NAC in breast cancer.
    Results Before NAC, VI and Emax were related to the degree of differentiation, pathological stage and HER-2 expression in breast cancer tissues (P < 0.05). The significant response group had higher change rates of VI and Emax at the end of 1, 2, and 4 week of NAC compared to the non-significant response group (P < 0.01). At the end of the second cycle, AUC of change rates of VI combined with Emax predicted the pathological response of NAC in breast cancer was 0.918, with the sensitivity of 0.874, and specificity of 0.905, which were higher than 0.832 of AUC, 0.78 of sensitivity, and 0.827 of specificity at the end of 1 week of NAC, and were higher than 0.853 of AUC, 0.827 of sensitivity, and 0.849 of specificity at the end of the fourth week.
    Conclusion VI and Emax are correlated with the degree of differentiation, pathological stage and HER-2 expression in breast cancer. At the end of the second cycle of chemotherapy, the change rates of the VI combined with Emax have the best efficacy in predicting the pathological reaction of NAC in breast cancer.

     

/

返回文章
返回